BioSpace News Archive

Humacyte, Inc. today announced positive results from a preclinical study of the small-diameter (3.5mm) HAV in a primate model simulating pediatric heart disease were presented at the American Heart Association’s (AHA) Scientific Sessions 2021.

CURE Pharmaceutical Holding Corp. announced today that it received an issue notification from the U.S. Patent Office (USPTO) stating that U.S. Patent No. 11,179,331 (the ’331 patent) is set to issue on November 23, 2021.

Selux Diagnostics, Inc. today announced that John Wilson has joined the company as Chief Commercial Officer.

Abyssinia Biologics, LLC, a biotechnology company focused on developing Alzheimer’s disease (AD) diagnostic and therapeutic monoclonal antibodies, today announced the publication of a study entitled, “An Ultra-sensitive Immunoassay Detects and Quantifies Soluble Aβ Oligomers in Human Plasma,” in the Journal Alzheimer’s and Dementia.

Applied Genetic Technologies Corporation, a biotechnology company conducting human clinical trials of adeno-associated virus -based gene therapies for the treatment of rare inherited retinal diseases, announced the appointment of Abraham Scaria, Ph.D., as Chief Science Officer.

Vaxart, Inc. (NASDAQ: VXRT) announced today the Journal of Infectious Diseases has published complete data from Vaxart’s preclinical Hamster Challenge Study.

AIVITA Biomedical, Inc. today announced that chairman and CEO Dr. Hans S. Keirstead will deliver a keynote at the Vaccine World Asia Congress. The Singapore -based congress is being held virtually November 17-18 .

LENSAR, Inc., a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, announced Nick Curtis, Chief Executive Officer will present at two upcoming investor conferences.

Apnimed, today announced positive topline results from a proof-of-concept randomized, controlled, double-blind, single-dose, three-period crossover study (protocol APX-001) in patients with OSA evaluating AD504 and AD182.

VBI Vaccines Inc. today announced that Jeff Baxter, President and CEO, will participate in an analyst-led fireside chat at the Jefferies London Healthcare Conference on Wednesday, November 17 at 12:20 PM GMT / 7:20 AM ET.